Roivant Sciences (STU:87S) Interest Expense : €-44.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Roivant Sciences's interest expense for the three months ended in Dec. 2024 was € 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-44.4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Roivant Sciences's Operating Income for the three months ended in Dec. 2024 was € -262.0 Mil. Roivant Sciences's Interest Expense for the three months ended in Dec. 2024 was € 0.0 Mil. GuruFocus does not calculate Roivant Sciences's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Roivant Sciences Interest Expense Historical Data

The historical data trend for Roivant Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Interest Expense Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Interest Expense

-2.36

-6.39

-26.12

-32.00

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial														-	-32.00	-12.45	-	-

Roivant Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-44.4 Mil.

Roivant Sciences (STU:87S) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Roivant Sciences's Interest Expense for the three months ended in Dec. 2024 was €0.0 Mil. Its Operating Income for the three months ended in Dec. 2024 was €-262.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €86.4 Mil.

Roivant Sciences's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

GuruFocus does not calculate Roivant Sciences's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Roivant Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ROIV:USA

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines